Merck & Co. voluntarily ceased worldwide Vioxx sales on September 30, 2004, citing risks of heart attack and stroke.
Delivering Justice Vioxx Recall Attorneys
If you or a loved one has suffered cardiovascular problems, stroke, heart attack, or death after taking the prescription drug Vioxx, you may be entitled to compensation from the pharmaceutical company that made the drug.
GoldenbergLaw, PLLC is a nationwide personal injury law firm located in downtown Minneapolis, Minnesota. Our defective drug lawyers help individuals injured by Vioxx get the compensation they deserve.
Vioxx – An Overview
In May 1999, the US Food and Drug Administration approved the drug Vioxx (generic name, rofecoxib) for the treatment of osteoarthritis, menstrual pain and the management of acute pain in adults. Vioxx is a non-steroidal anti-inflammatory drug (NSAID), which reduces inflammation and relieves pain. Vioxx does not actually cure arthritis or other diseases that cause acute pain, but helps to alleviate their symptoms. In September 2004, Merck & Co., Inc. (Merck), the manufacturer of Vioxx, voluntarily withdrew Vioxx from the market citing an increased risk of cardiovascular problems, including heart attack and stroke, in individuals who took the drug. If you took Vioxx and experienced adverse side effects, talk to your doctor as soon as possible. In addition, contact an attorney who has experience with product liability litigation.
Vioxx Safety Timeline
In November 1998, Merck sought approval from the US Food and Drug Administration (FDA) for Vioxx (generic name, rofecoxib), after having tested the drug on 5400 people in eight studies. In May 1999, the FDA approved Vioxx for the treatment of osteoarthritis, menstrual pain and the management of acute pain in adults. Merck voluntarily withdrew Vioxx from the market in September 2004. This article highlights some of the key dates of studies, articles and other events regarding the safety of Vioxx. If you have questions about Vioxx, contact your doctor or an attorney who has handled Vioxx litigation.
Overview of Vioxx Litigation
Claims against Merck & Co., Inc. (Merck) over Vioxx began to be filed in 2001, and really took off after Merck voluntarily removed Vioxx from the market in September 2004. In total, almost 27,000 lawsuits have been filed against the company. Merck’s strategy was to fight every case. This is contrary to what many companies do when faced with an extremely large number of claims — try to obtain a quick settlement, even if it is expensive. The following article highlights some of the major decisions leading up to the November 2007 settlement. If you have questions about the Vioxx litigation, talk to an experienced product liability attorney.
On November 9, 2007, Merck & Co., Inc. (Merck), the manufacturer of Vioxx, announced that it had entered into a settlement agreement in which it agreed to pay $4.85 billion into a settlement fund to resolve qualifying claims. Merck did not admit any fault, liability or wrongdoing, and will continue to defend all claims that are not part of the settlement process. If you have a pending claim against Merck and have questions about how this settlement will affect you, contact a lawyer who has experience handling Vioxx cases.
Pharmaceutical Liability Litigation
“Pharmaceutical liability” is the term used to describe the legal consequences a manufacturer of drugs may face if its products injure people. Cases involving injuries caused by drugs, such as Vioxx, medical devices and other pharmaceuticals are a subset of products liability cases. Drugs and other pharmaceuticals can have several defects, including design defects, manufacturing defects, problems with the testing of the drug, inadequate warnings or improper instructions for use. Any of these problems can cause serious injuries. If you believe that a medicine, herbal supplement or medical device, such as a heart valve, has caused you to suffer from serious, adverse side effects or other injuries, an experienced pharmaceutical liability attorney can evaluate your situation and explain your options for recovery.
The Center for Drug Evaluation and Research (CDER) is the division of the US Food and Drug Administration (FDA) that is responsible for evaluating and approving new prescription, generic and over-the-counter drugs before they can be sold. It is the CDER’s job to ensure that these drugs work correctly and that their health benefits outweigh known risks. CDER is also responsible for overseeing the research, development, manufacture and marketing of drugs; ensuring that advertisements for prescription drugs are truthful; and monitoring drugs that have been approved for unexpected health issues. If health risks are discovered after a drug is approved, CDER informs the public of the risk, ensures that changes are made to the drug’s label and, if it is necessary, removes the drug from the market. If you have questions about the approval or removal of a particular drug from the market, health risks related to a drug or litigation regarding those risks, talk to an attorney.
If you have any questions, or if you would like to speak with an attorney regarding health problems caused by your use of Vioxx, please do not hesitate to call our downtown Minneapolis office toll-free at 877-544-1757. If you prefer, you may fill out the form on the Contact Us page of this web site, and a representative from our office will be in touch with you shortly. We look forward to hearing from you!
When you retain the services of GoldenbergLaw, PLLC, you retain attorneys who are dedicated to your cause and work hard to achieve results for you. You will only owe attorneys’ fees in a Vioxx case when we obtain a recovery for you.
Contact the Vioxx Recall Attorneys at GoldenbergLaw, PLLC for a free initial consultation.